Article Text

Download PDFPDF
What is the prototype of familial amyloid polyneuropathy?
  1. Haruki Koike,
  2. Gen Sobue
  1. Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  1. Correspondence to Dr Haruki Koike, Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; koike-haruki{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Familial amyloid polyneuropathy (FAP) is a hereditary form of amyloidosis most commonly caused by mutations in transthyretin (TTR) and was initially reported from endemic foci in Portugal, Japan and Sweden. However, development in gene diagnostic techniques revealed that FAP patients are more widely distributed and have varied phenotypes even in the same mutation.1 ,2 For example, Japanese patients who have early onset FAP with amyloidogenic TTR Val30Met mutation (FAP amyloidogenic transthyretin (ATTR) Val30Met) in endemic foci in Kumamoto and Nagano prefectures exhibit clinicopathological features distinct from those of late-onset FAP ATTR Val30Met patients in non-endemic areas.2 Because late-onset FAP ATTR Val30Met in non-endemic areas is now more prevalent than expected, this entity may represent …

View Full Text


  • Contributors All authors participated in the conception and writing of this paper.

  • Funding This work was supported by grants from the Ministry of Health, Labour and Welfare (Research on intractable diseases, H23-012).

  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles